Cystic Fibrosis is categorized under Noncommercial Research Organizations in Los Angeles, CA .
Cystic Fibrosis was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 6219993 by the NAICS.
If you are seeking more information, feel free to contact Zendy Solero at the company’s single location by writing to 4929 Wilshire Boulevard # 760, Los Angeles, California CA 90010 or by phoning (323) 939-0758. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cystic Fibrosis |
| Contact Person: | Zendy Solero |
| Address: | 4929 Wilshire Boulevard # 760, Los Angeles, California 90010 |
| Phone Number: | (323) 939-0758 |
| Website Address: | cff.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 6219993 |
| Share This Business: |
Cystic Fibrosis was started in 0 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Zendy Solero for inquiries that concern Cystic Fibrosis by calling the company number (323) 939-0758, as your correspondence is most welcome. Additionally, the physical location of the single location of Cystic Fibrosis can be found at the coordinates 34.062162,-118.33805 as well as the street address 4929 Wilshire Boulevard # 760 in Los Angeles, California 90010.
For its online presence, you may visit Cystic Fibrosis’s website at cff.org and engage with its social media outlets through on Twitter and on Facebook.